SPRO vs. TQQQ
SPRO (Spero Therapeutics, Inc.) is a stock, while TQQQ (ProShares UltraPro QQQ) is Leveraged Equities fund tracking the NASDAQ-100 Index (300%). Over the past 5 years, SPRO returned -34.67%/yr vs 19.60%/yr for TQQQ. At a 0.26 correlation, their price movements are largely independent.
Performance
SPRO vs. TQQQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPRO achieves a -27.04% return, which is significantly lower than TQQQ's 42.86% return.
SPRO
- 1D
- -22.02%
- 1M
- -40.35%
- 6M
- -30.61%
- YTD
- -27.04%
- 1Y
- -35.61%
- 3Y*
- 4.03%
- 5Y*
- -34.67%
- 10Y*
- —
TQQQ
- 1D
- 3.28%
- 1M
- -3.00%
- 6M
- 35.46%
- YTD
- 42.86%
- 1Y
- 78.48%
- 3Y*
- 52.21%
- 5Y*
- 19.60%
- 10Y*
- 42.73%
SPRO vs. TQQQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SPRO Spero Therapeutics, Inc. | -27.04% | 126.21% | -29.93% | -15.03% | -89.19% | -17.43% | 101.66% | 56.34% | -47.66% | -11.32% |
TQQQ ProShares UltraPro QQQ | 42.86% | 34.35% | 58.27% | 198.04% | -79.09% | 82.98% | 110.05% | 133.84% | -19.79% | 6.89% |
Correlation
The correlation between SPRO and TQQQ is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Nov 2, 2017 | 0.26 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPRO vs. TQQQ — Risk / Return Rank
SPRO
TQQQ
SPRO vs. TQQQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Spero Therapeutics, Inc. (SPRO) and ProShares UltraPro QQQ (TQQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SPRO | TQQQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.99 | ||
| Sortino ratioReturn per unit of downside risk | -2.37 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.25 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | -0.83 | 2.13 | -2.97 |
| Martin ratioReturn relative to average drawdown | -2.50 | 6.53 | -9.03 |
Loading charts...
Drawdowns
SPRO vs. TQQQ - Drawdown Comparison
The maximum SPRO drawdown since its inception was -97.46%, which is greater than TQQQ's maximum drawdown of -81.66%. Use the drawdown chart below to compare losses from any high point for SPRO and TQQQ.
Loading charts...
Drawdown Indicators
| SPRO | TQQQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.46% | -81.66% | -15.80% |
Max Drawdown (1Y)Largest decline over 1 year | -42.95% | -36.97% | -5.98% |
Max Drawdown (3Y)Largest decline over 3 years | -68.89% | -58.04% | -10.85% |
Max Drawdown (5Y)Largest decline over 5 years | -97.13% | -81.66% | -15.47% |
Max Drawdown (10Y)Largest decline over 10 years | — | -81.66% | — |
Current DrawdownCurrent decline from peak | -92.30% | -13.79% | -78.51% |
Average DrawdownAverage peak-to-trough decline | -62.61% | -18.48% | -44.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.92% | 12.05% | +3.87% |
Volatility
SPRO vs. TQQQ - Volatility Comparison
Spero Therapeutics, Inc. (SPRO) has a higher volatility of 40.57% compared to ProShares UltraPro QQQ (TQQQ) at 23.84%. This indicates that SPRO's price experiences larger fluctuations and is considered to be riskier than TQQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPRO | TQQQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 40.57% | 23.84% | +16.73% |
Volatility (6M)Calculated over the trailing 6-month period | 52.69% | 45.82% | +6.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 63.53% | 55.29% | +8.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 152.30% | 67.76% | +84.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 124.80% | 66.41% | +58.39% |
Dividends
SPRO vs. TQQQ - Dividend Comparison
SPRO has not paid dividends to shareholders, while TQQQ's dividend yield for the trailing twelve months is around 0.50%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPRO Spero Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TQQQ ProShares UltraPro QQQ | 0.50% | 0.65% | 1.27% | 1.26% | 0.57% | 0.00% | 0.00% | 0.06% | 0.11% | 0.00% | 0.00% | 0.01% |
Frequently Asked Questions
SPRO and TQQQ have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SPRO has higher volatility (40.57%) compared to TQQQ (23.84%). In terms of maximum drawdown, SPRO dropped -97.46% vs TQQQ's -81.66%.
TQQQ currently has the higher Sharpe Ratio (1.43 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SPRO and TQQQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer